New legislation, key court cases, and trends affecting patents, marketing, privacy, product liability, and more.
February 1, 2012
By:John Shaeffer, Brianna Dahlberg
State tech transfer laws giving universities automatic ownership of employees' inventions represent a threat to pharma partnerships.
 |
 | January 1, 2012
By:Jennifer Ringler
Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
|
July 1, 2011
By:Todd C. Davis
Structuring a good deal depends on understanding your partner—and a high degree of specificity
|
May 1, 2011
By:John Brenner
To what extent are generics companies obligated by law to request labeling changes with FDA?
|
 | March 1, 2011
The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process
|
December 1, 2010
By:Anjali Chaturvedi, Brian K. French
Stepped-up enforcement of the Foreign Corrupt Practices Act requires enhanced global coordination of compliance
|
September 1, 2010
By:Mark Pohl
If companies aren't careful with their marketing spend, they could, in fact, wind up getting too much bang for their buck
|
August 1, 2010
By:Daniel Reisner
A recent Supreme Court decision leaves open the debate on patent eligibility requirements.
|
April 29, 2009
The final part in our series on how to draft enforceable post-employment restriction agreements that will protect trade secrets and customer goodwill.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
